| # | Country | Total Patents | |
|---|---|---|---|
| #1 | Republic of Korea | 7 | |
| #2 | Brazil | 5 | |
| #3 | United States | 4 | |
| #4 | WIPO (World Intellectual Property Organization) | 4 | |
| #5 | EPO (European Patent Office) | 3 | |
| #6 | Israel | 3 | |
| #7 | Australia | 2 | |
| #8 | Canada | 2 | |
| #9 | Colombia | 2 | |
| #10 | Mexico | 2 | |
| #11 | Italy | 1 | |
| #12 | Serbia | 1 | |
| #13 | Singapore | 1 |
| # | Industry | |
|---|---|---|
| #1 | Pharmaceuticals | |
| #2 | Organic fine chemistry |
| # | Technology | |
|---|---|---|
| #1 | Therapeutic chemical compounds | |
| #2 | Medical preparations | |
| #3 | Heterocyclic compounds |
| # | Name | Total Patents |
|---|---|---|
| #1 | Barchielli Marco | 18 |
| #2 | Menegon Sergio | 15 |
| #3 | Mattei Alberto | 9 |
| #4 | Graziani Davide | 9 |
| #5 | Riva Carlo | 9 |
| #6 | Farina Pierluigi | 8 |
| #7 | Provvedini Diego | 8 |
| #8 | Berlati Fabio | 8 |
| #9 | Marco Barchielli | 6 |
| #10 | Tazzari Valerio | 6 |
| Publication | Filing date | Title |
|---|---|---|
| WO2020239882A1 | Pharmaceutical formulation for carglumic acid | |
| KR20200120915A | Triazole, imidazole and pyrrole condensed piperazine derivatives as modulators of mGlu5 receptors and their use | |
| KR20200023370A | Heterocyclylmethylidene Derivatives and Uses thereof as Modulators of mGluR5 Receptors | |
| EP3572068A1 | New salt of cysteamine for the preparation of highly respirable particles | |
| KR20180120268A | A sustained-release pharmaceutical composition comprising cysteamine or a salt thereof | |
| EP3323410A1 | Pharmaceutical parenteral formulation containing carglumic acid |